These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1714041)

  • 21. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance-P antagonists: effect on spontaneous and drug-induced locomotor activity in the rat.
    Elliott PJ; Iversen SD
    Neuropharmacology; 1987 May; 26(5):419-22. PubMed ID: 2439936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in mice.
    Tan-No K; Sakurada T; Yamada T; Sakurada S; Kisara K
    Neuropeptides; 1995 Nov; 29(5):293-9. PubMed ID: 8587665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the tachykinin antagonist, [D-Pro4, D-Trp7,9,10] substance P-(4-11), on tachykinin- and histamine-induced inositol phosphate generation in intestinal smooth muscle.
    Bailey SJ; Lippe IT; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):296-300. PubMed ID: 2438561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capsaicin pretreatment does not inhibit the opioid withdrawal response in guinea-pigs.
    Chahl LA
    Eur J Pharmacol; 1988 Dec; 158(1-2):91-8. PubMed ID: 3220120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Injection of Gamma-Aminobutyric Acid Agonists into the Nucleus Accumbens on Naloxone-Induced Morphine Withdrawal.
    Topkara B; Yananli HR; Sakallı E; Demirkapu MJ
    Pharmacology; 2017; 100(3-4):131-138. PubMed ID: 28637045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
    Maldonado R; Valverde O; Derrien M; Tejedor-Real P; Roques BP
    Pharmacol Biochem Behav; 1994 Jun; 48(2):363-9. PubMed ID: 8090802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the bronchoconstrictor and cardiovascular effects of some tachykinins in guinea pigs.
    Goel V; Biggs DF
    Life Sci; 1987 Mar; 40(10):1007-15. PubMed ID: 2434817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma catecholamine concentrations during morphine withdrawal in conscious guinea-pigs.
    Brent PJ; Johnston PA; Chahl LA
    Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):623-31. PubMed ID: 3440321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indole alkaloids from Sickingia williamsii reduce the in-vitro effects of morphine withdrawal in the guinea-pig.
    Capasso A; Aquino R; Garofalo L; De Simone F; Sorrentino L
    J Pharm Pharmacol; 1997 Jul; 49(7):712-4. PubMed ID: 9255716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tachykinin antagonists have potent local anaesthetic actions.
    Post C; Butterworth JF; Strichartz GR; Karlsson JA; Persson CG
    Eur J Pharmacol; 1985 Nov; 117(3):347-54. PubMed ID: 2416579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma catecholamines and locomotor activity induced by centrally administered substance P in guinea-pigs.
    Brent PJ; Johnston PA; Chahl LA
    Neuropharmacology; 1988 Jul; 27(7):743-8. PubMed ID: 2458534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity.
    Wiesenfeld-Hallin Z; Xu XJ; Kristensson K; Håkanson R; Feng DM; Folkers K
    Regul Pept; 1990 Jun; 29(1):1-11. PubMed ID: 1697080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
    Pinelli A; Cighetti G; Trivulzio S
    Arzneimittelforschung; 2009; 59(2):72-8. PubMed ID: 19338137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.
    Folkers K; Feng DM; Asano N; Håkanson R; Weisenfeld-Hallin Z; Leander S
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4833-5. PubMed ID: 1693780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
    Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
    Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orphanin FQ/nociceptin inhibits morphine withdrawal.
    Kotlińska J; Suder P; Legowska A; Rolka K; Silberring J
    Life Sci; 2000 Jan; 66(8):PL119-23. PubMed ID: 10680585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.